DM controls does not affect outcomes after knee arthroplasty

This large retrospective cohort of patients undergoing elective knee arthroplasty found HbA1c above or below 7% did not affect any major outcomes (VTE, revisions, infections, readmissions, or AMI). There is not a clear correlation between preop HbA1c levels and postop outcomes (abstract).

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment